PROCEPT BioRobotics Corp (PRCT)
94.45
+1.75
(+1.89%)
USD |
NASDAQ |
Nov 21, 16:00
93.66
-0.79
(-0.84%)
After-Hours: 20:00
PROCEPT BioRobotics Gross Profit Margin (Quarterly): 63.24% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 63.24% |
| June 30, 2024 | 59.01% |
| March 31, 2024 | 56.21% |
| December 31, 2023 | 48.77% |
| September 30, 2023 | 53.77% |
| June 30, 2023 | 55.67% |
| March 31, 2023 | 51.18% |
| December 31, 2022 | 44.90% |
| September 30, 2022 | 50.28% |
| Date | Value |
|---|---|
| June 30, 2022 | 50.84% |
| March 31, 2022 | 54.18% |
| December 31, 2021 | 44.55% |
| September 30, 2021 | 48.92% |
| June 30, 2021 | 42.27% |
| March 31, 2021 | 49.04% |
| December 31, 2020 | 14.59% |
| September 30, 2020 | -1.47% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-1.47%
Minimum
Sep 2020
63.24%
Maximum
Sep 2024
46.23%
Average
50.28%
Median
Sep 2022
Gross Profit Margin (Quarterly) Benchmarks
| Boston Scientific Corp | 68.83% |
| Intuitive Surgical Inc | 67.41% |
| Teleflex Inc | 56.28% |
| Perspective Therapeutics Inc | -- |
| Xtant Medical Holdings Inc | 58.37% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -37.42% |
| Return on Assets | -25.56% |
| Return on Invested Capital | -31.39% |
| Profit Margin (Quarterly) | -35.93% |
| Operating Margin (Quarterly) | -38.42% |
| Return on Net Operating Assets | -65.23% |